Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Nuzzo

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Drug and Alcohol Dependence|April 1, 2015
Characterizing opioid withdrawal during double-blind buprenorphine detoxificationKelly E Dunn, Kathryn A Saulsgiver, Mollie E Miller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related InfectionsLaura C Fanucchi, Sharon L Walsh, Alice C Thornton, et al.
Journal of Opioid Management|September 10, 2009
Prescription drug fatalities among women in rural Virginia: a study of medical examiner casesMartha J Wunsch, Kent Nakamoto, Paul A Nuzzo, et al.
Addiction (Abingdon, England)|March 15, 2011
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusersLisa S Middleton, Paul A Nuzzo, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|June 13, 2013
Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trialMichelle R Lofwall, Shanna Babalonis, Paul A Nuzzo, et al.
Experimental and Clinical Psychopharmacology|June 13, 2012
Intranasal oxycodone self-administration in non-dependent opioid abusersLisa S Middleton, Michelle R Lofwall, Paul A Nuzzo, et al.
Journal of Clinical Psychopharmacology|June 15, 2016
A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical TrialsAidan J Hampson, Shanna Babalonis, Michelle R Lofwall, et al.
Archives of Internal Medicine|December 12, 2007
QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trialErich F Wedam, George E Bigelow, Rolley E Johnson, et al.
Psychopharmacology|June 16, 2019
Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humansShanna Babalonis, Michelle R Lofwall, Paul A Sloan, et al.
Drug and Alcohol Dependence|October 21, 2015
Safety of oral dronabinol during opioid withdrawal in humansCrystal J Jicha, Michelle R Lofwall, Paul A Nuzzo, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Drug and Alcohol Dependence|April 1, 2015
Characterizing opioid withdrawal during double-blind buprenorphine detoxificationKelly E Dunn, Kathryn A Saulsgiver, Mollie E Miller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related InfectionsLaura C Fanucchi, Sharon L Walsh, Alice C Thornton, et al.
Journal of Opioid Management|September 10, 2009
Prescription drug fatalities among women in rural Virginia: a study of medical examiner casesMartha J Wunsch, Kent Nakamoto, Paul A Nuzzo, et al.
Addiction (Abingdon, England)|March 15, 2011
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusersLisa S Middleton, Paul A Nuzzo, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|June 13, 2013
Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trialMichelle R Lofwall, Shanna Babalonis, Paul A Nuzzo, et al.
Experimental and Clinical Psychopharmacology|June 13, 2012
Intranasal oxycodone self-administration in non-dependent opioid abusersLisa S Middleton, Michelle R Lofwall, Paul A Nuzzo, et al.
Journal of Clinical Psychopharmacology|June 15, 2016
A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical TrialsAidan J Hampson, Shanna Babalonis, Michelle R Lofwall, et al.
Archives of Internal Medicine|December 12, 2007
QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trialErich F Wedam, George E Bigelow, Rolley E Johnson, et al.
Psychopharmacology|June 16, 2019
Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humansShanna Babalonis, Michelle R Lofwall, Paul A Sloan, et al.
Drug and Alcohol Dependence|October 21, 2015
Safety of oral dronabinol during opioid withdrawal in humansCrystal J Jicha, Michelle R Lofwall, Paul A Nuzzo, et al.
Pageof 5